Projects / Programmes
Vloga hemostaticnih dejavnikov v zdravljenju akutnega koronarnega sindroma (Slovene)
Code |
Science |
Field |
Subfield |
3.06.00 |
Medical sciences |
Cardiovascular system |
|
Code |
Science |
Field |
B007 |
Biomedical sciences |
Medicine (human and vertebrates) |
B530 |
Biomedical sciences |
Cardiovascular system |
acute coronary syndrome, PAI-1, fibrinogen, mortality, urgent revascularization, transmural acute myocardial infarction, arrhythmias, heart failure
Researchers (2)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
18987 |
PhD Andreja Sinkovič |
Cardiovascular system |
Head |
2000 - 2002 |
584 |
2. |
13152 |
PhD Damijan Vokač |
Cardiovascular system |
Researcher |
2000 - 2002 |
164 |
Organisations (1)
Abstract
During the period of 2-3 years, 30-50 patients with acute coronary syndrome, that is unstable angina and/or nonQ acute myocardial infarction, will be included. We will study the role of hemostatic factors fibrinogen and PAI-1, estimated before and during therapy, in early (in-hospital) and late (after 6 monts) mortality of patients, in the need of urgent revaskularization and in the onset of complications (new transmural acute myocardial infarction, arrhythmias, and heart failure).